
Talphera, Inc. – NASDAQ:TLPH
Talphera stock price today
Talphera stock price monthly change
Talphera stock price quarterly change
Talphera key metrics
Market Cap | 10.51M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -0.89 |
Revenue | N/A |
EBITDA | -14.08M |
Income | -14.19M |
Revenue Q/Q | N/A |
Revenue Y/Y | -51.01% |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeTalphera stock price history
Talphera stock forecast
Talphera financial statements
Jun 2023 | 253K | -4.37M | -1727.67% |
---|---|---|---|
Sep 2023 | 117K | -1.35M | -1159.83% |
Dec 2023 | 281K | -4.51M | -1607.47% |
Mar 2024 | 0 | -3.95M |
Sep 2023 | 117K | -1.35M | -1159.83% |
---|---|---|---|
Dec 2023 | 281K | -4.51M | -1607.47% |
Mar 2024 | 0 | -3.95M | |
Dec 2025 | 580K | 0 |
Analysts Price target
Financials & Ratios estimates
Jun 2023 | 17725000 | 7.30M | 41.22% |
---|---|---|---|
Sep 2023 | 23261000 | 4.95M | 21.3% |
Dec 2023 | 20395000 | 6.29M | 30.84% |
Mar 2024 | 28772000 | 12.43M | 43.23% |
Jun 2023 | -5.33M | 2.72M | -3.33M |
---|---|---|---|
Sep 2023 | -2.96M | 0 | 8.93M |
Dec 2023 | -3.94M | -3.65M | -68K |
Mar 2024 | -2.88M | -2.73M | 12.01M |
Talphera alternative data
Jun 2024 | 15 |
---|---|
Jul 2024 | 15 |
Talphera other data
Period | Buy | Sel |
---|---|---|
Jun 2024 | 10000 | 0 |
Aug 2024 | 7260 | 0 |
Nov 2024 | 5000 | 0 |
Dec 2024 | 5000 | 155 |
Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
---|---|---|---|---|---|---|---|
Purchase | ANGOTTI VINCENT J. director, officer.. | Common Stock | 5,000 | $0.64 | $3,200 | ||
Sale | ASADORIAN RAFFI officer: Chief Fi.. | Common Stock | 155 | $0.77 | $119 | ||
Purchase | ANGOTTI VINCENT J. director, officer.. | Common Stock | 5,000 | $0.73 | $3,650 | ||
Purchase | ANGOTTI VINCENT J. director, officer.. | Common Stock | 7,260 | $1.05 | $7,601 | ||
Purchase | ANGOTTI VINCENT J. director, officer.. | Common Stock | 1,304 | $1.08 | $1,404 | ||
Purchase | ANGOTTI VINCENT J. director, officer.. | Common Stock | 4,570 | $0.97 | $4,437 | ||
Purchase | ANGOTTI VINCENT J. director, officer.. | Common Stock | 4,126 | $0.97 | $4,015 |
Quarter | Transcript |
---|---|
Q1 2024 14 May 2024 | Q1 2024 Earnings Call Transcript |
Q4 2023 6 Mar 2024 | Q4 2023 Earnings Call Transcript |
-
What's the price of Talphera stock today?
One share of Talphera stock can currently be purchased for approximately $0.42.
-
When is Talphera's next earnings date?
Unfortunately, Talphera's (TLPH) next earnings date is currently unknown.
-
Does Talphera pay dividends?
No, Talphera does not pay dividends.
-
How much money does Talphera make?
Talphera has a market capitalization of 10.51M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 63.24% to 651K US dollars.
-
What is Talphera's stock symbol?
Talphera, Inc. is traded on the NASDAQ under the ticker symbol "TLPH".
-
What is Talphera's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of Talphera?
Shares of Talphera can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Talphera have?
As Jul 2024, Talphera employs 15 workers.
-
When Talphera went public?
Talphera, Inc. is publicly traded company for more then 14 years since IPO on 11 Feb 2011.
-
What is Talphera's official website?
The official website for Talphera is talphera.com.
-
Where are Talphera's headquarters?
Talphera is headquartered at 1850 Gateway Drive, San Mateo, CA.
-
How can i contact Talphera?
Talphera's mailing address is 1850 Gateway Drive, San Mateo, CA and company can be reached via phone at +65 02163500.
Talphera company profile:

Talphera, Inc.
talphera.comNASDAQ
15
Drug Manufacturers - Specialty & Generic
Healthcare
Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including COVID-19, disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. Talphera, Inc. was incorporated in 2005 and is headquartered in San Mateo, California.
San Mateo, CA 94404
CIK: 0001427925
ISIN: US00444T2096
: